Global Market TrendsOne biotech stock is ‘oncology powerhouse’ with 40% upside, says TruistadminFffFF0or31rJanuary 10, 2025 by adminFffFF0or31rJanuary 10, 2025012 BioNTech SE could evolve into an “oncology powerhouse” after emerging as a premier vaccine player during the Covid-19 pandemic, according to Truist Securities. The investment...
